Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy
Authors:
- 1 January 2016
- journal article
- review article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 13 (1) , 101-108
Abstract
Obstructive sleep apnea (OSA) is a common sleep disorder with serious associated morbidities. Although several treatment options are currently available, variable efficacy and adherence result in many patients either not being treated or receiving inadequate treatment long term. Personalized treatment based on relevant patient characteristics may improve adherence to treatment and long-term clinical outcomes. Four key traits of upper airway anatomy and neuromuscular control interact to varying degrees within individuals to cause OSA. These are: (1) the pharyngeal critical closing pressure, (2) the stability of ventilator chemoreflex feedback control (loop gain), (3) the negative intraesophageal pressure that triggers arousal (arousal threshold), and (4) the level of stimulus required to activated upper airway dilator muscles (upper airway recruitment threshold). Simplified diagnostic methods are being developed to assess these pathophysiological traits, potentially allowing prediction of which treatment would best suit each patient. In contrast to current practice of using various treatment modes alone, model predictions and pilot clinical trials show improved outcomes by combining several treatments targeted to each patient’s pathophysiology profile. These developments could theoretically improve efficacy and adherence to treatment and in turn reduce the social and economic health burden of OSA and the associated life-threatening morbidities. This article reviews OSA pathophysiology and identifies currently available and investigational treatments that may be combined in the future to optimize therapy based on individual profiles of key patient pathophysiological traits.Keywords
This publication has 87 references indexed in Scilit:
- The undervalued potential of positional therapy in position-dependent snoring and obstructive sleep apnea—a review of the literatureSleep and Breathing, 2012
- Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoeaThe Journal of Physiology, 2012
- Sensory plasticity of the carotid body: Role of reactive oxygen species and physiological significanceRespiratory Physiology & Neurobiology, 2011
- Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal thresholdClinical Science, 2011
- Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxiaRespiratory Physiology & Neurobiology, 2010
- Increased Propensity for Central Apnea in Patients with Obstructive Sleep Apnea: Effect of Nasal Continuous Positive Airway PressureAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Progressive augmentation and ventilatory long‐term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administrationThe Journal of Physiology, 2009
- The Impact of Obesity on Oxygen Desaturation during Sleep-disordered BreathingAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Adherence to Continuous Positive Airway Pressure Therapy: The Challenge to Effective TreatmentProceedings of the American Thoracic Society, 2008
- Trazodone increases arousal threshold in obstructive sleep apnoeaEuropean Respiratory Journal, 2008